Disease-A-Month
Volume 52, Issue 11 , Pages 441-445 , November 2006

Latent Tuberculous Infection

References 

  1. American Thoracic Society. Targeted tuberculin testing and treatment of latent tuberculosis infection. Am J Respir Crit Care Med. 2000;161:S221–S247
  2. American Thoracic Society and Centers for Disease Control and Prevention. Diagnostic standards and classification of tuberculosis in adults and children. Am J Respir Crit Care Med. 2000;161:1376–1395
  3. American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America. Controlling Tuberculosis in the United States. Am J Respir Crit Care Med. 2005;172:1169–1227
  4. Blumberg HM, Leonard MK, Jasmer RM. Update on treatment of tuberculosis and latent tuberculosis infection. JAMA. 2005;293:2776–2784
  5. Centers for Disease Control and Prevention. Guidelines for using the QuantiFERON-TB test for diagnosing latent Mycobacterium tuberculosis infection. MMWR Recomm Rep. 2003;52(RR-2):15–18
  6. American Thoracic Society and Centers for Disease Control and Prevention. Update: Fatal and Severe Liver Injuries Associated with Rifampin and Pyrazinamide for Latent Tuberculosis Infection, and Revisions in American Thoracic Society/CDC Recommendations—United States, 2001. Am J Respir Crit Care Med. 2001;164:1319–1320

PII: S0011-5029(06)00092-7

doi: 10.1016/j.disamonth.2006.09.009

Disease-A-Month
Volume 52, Issue 11 , Pages 441-445 , November 2006